| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 10/07/2004 | US20040199944 Comprises fusion protein coding optimized transit peptide for use in the generation of herbicide resistant plants; tissue engineering |
| 10/07/2004 | US20040198961 Fce fusion proteins for treatment of allergy and asthma |
| 10/07/2004 | US20040198952 Polyclonal and monoclonal antibodies for use in bioassay for detection of immunosuppressants or imnnunosuppressant peptides |
| 10/07/2004 | US20040197892 Composition binding polypeptides |
| 10/07/2004 | US20040197876 Recombinant fusion proteins and the trimers thereof |
| 10/07/2004 | US20040197859 useful for treatment of migraine headaches/prophylaxis, menopausal hot flashes, chronic tension type headache, cluster headache, neurogenic or chronic inflammation, gastrointestinal disorders, type 2 diabetes and cardiovascular disorders |
| 10/07/2004 | US20040197346 Materials and methods for intracellular transport and their uses |
| 10/07/2004 | CA2520254A1 Treatment of viral infections |
| 10/07/2004 | CA2520138A1 Improved fc fusion proteins |
| 10/07/2004 | CA2518792A1 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 10/06/2004 | EP1463942A2 Methods for purifying protein |
| 10/06/2004 | EP1463928A2 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 10/06/2004 | EP1463755A2 Recombinant polypeptides |
| 10/06/2004 | EP1463751A2 Albumin fusion proteins |
| 10/06/2004 | EP1349868B1 Process to concentrate insoluble proteins by vibrating membrane filtration |
| 10/06/2004 | EP0828842B1 Novel fusion protein recovery and purification methods |
| 10/06/2004 | CN1535283A Process for preparation of polypeptides of interest from fusion polypeptides |
| 10/06/2004 | CN1535281A Peptides and related molecules that bind to TALL-1 |
| 10/06/2004 | CN1169827C Method for improving stability of polypeptide in body and its application |
| 10/05/2004 | US6800735 Interferon-beta fusion proteins and uses |
| 09/30/2004 | WO2003072740A3 Novel type-1 cytokine receptor glm-r |
| 09/30/2004 | WO2003062447A3 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 09/30/2004 | WO2003039491A3 Novel isoforms of vascular endothelial cell growth inhibitor |
| 09/30/2004 | US20040192892 Isolated mammalian membrane protein genes; related reagents |
| 09/30/2004 | US20040191826 Dipeptidyl peptidases |
| 09/30/2004 | US20040191825 Using pyrococcus polymerase fusion to replicate preferential nucleotide sequences; polynucleotide amplification tool; genetic engineering |
| 09/30/2004 | US20040191805 Nucleotide sequences coding g-protein coupled receptors for identifying modulators of sweet taste transduction; sweetners and flavoring; tastands and food treatment |
| 09/30/2004 | US20040191767 Comprises nucleotide sequences coding hepatitis core protein fusion for generating vaccine to prevent infcetion and treat liver dysfunction; gene therapy and cell-mediated immune response |
| 09/30/2004 | US20040191261 Genetically engineered fusion protein comprising fibrin/fibrinogen binding moiety such as endothelial growth factor (VEGF165) C-terminal domain fused to a wound healing agent such as leptin |
| 09/29/2004 | EP1462114A1 Methods and means to suppress symptons of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (GRIT or TNFRSF18) |
| 09/29/2004 | EP1461360A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 09/29/2004 | EP1461358A1 Ifnar2 muteins, their production and use |
| 09/29/2004 | EP1461069A2 Combined use of a glp-1 compound and another drug for treating dyslipidemia |
| 09/29/2004 | EP1005486A4 Inducible regulatory system and use thereof |
| 09/29/2004 | CN1168830C Construction and expression of recombinant human B cell stimulating factor (rhBLyS) expression vector, monoclonal antibody preparation and use |
| 09/28/2004 | US6797809 Multiple fusion antigens for use in immunoassays for anti-HCV antibodies |
| 09/28/2004 | US6797489 PP14 fusion proteins and methods for making and using the same |
| 09/28/2004 | US6797467 Compositions and methods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions |
| 09/24/2004 | CA2517496A1 Intracellular delivery of osteoinductive proteins and peptides |
| 09/23/2004 | WO2004081053A1 Physiologically active polypeptide conjugate having prolonged in vivo half-life |
| 09/23/2004 | WO2004081052A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies |
| 09/23/2004 | WO2004080387A2 Immunogenic cd19 ligand-antigenic molecule complexes and fusion proteins |
| 09/23/2004 | WO2003106621A3 Anti-igf-i receptor antibody |
| 09/23/2004 | WO2003102157A3 Synthetic antibody phage libraries |
| 09/23/2004 | WO2003086175A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/23/2004 | WO2003072017A3 Macromolecular conjugates and processes for preparing same |
| 09/23/2004 | WO2003068809A8 An herpes simplex virus complex |
| 09/23/2004 | US20040185033 Tumor antigens and CTL clones isolated by a novel procedure |
| 09/23/2004 | CA2518549A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies |
| 09/23/2004 | CA2515286A1 Immunogenic cd19 ligand-antigenic molecule complexes and fusion proteins |
| 09/22/2004 | EP1458866A2 Modified tridegins, production and use thereof as transglutaminase inhibitors |
| 09/22/2004 | EP1458755A2 Novel g-protein coupled receptors and dna sequences thereof |
| 09/22/2004 | EP1458754A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 09/22/2004 | EP1458752A2 Polypeptides of pseudomonas aeruginosa |
| 09/22/2004 | EP0915970B1 Type c lectins |
| 09/22/2004 | EP0882123B1 Process for removal or bleaching of soiling or stains from cellulosic fabric |
| 09/22/2004 | EP0636179B1 Oil-body proteins as carriers of high-value peptides in plants |
| 09/22/2004 | CN1531590A Aspergillus ocharceus 11 alpha hydroxylase and oxidoreductase |
| 09/22/2004 | CN1531552A Chimeric proteins for cell targeting and apoptosis induction and methods of using same |
| 09/22/2004 | CN1531551A Production of insulinotropic secretion peptide GLP-1(7-36) and GLP-1 analog |
| 09/22/2004 | CN1531549A Pharmaceutical use for secreted bacterial effector proteins |
| 09/22/2004 | CN1531548A Chimeric chains that code for proteins that induce effects directed against viruses |
| 09/22/2004 | CN1531545A Reducing immunogenicity of fusion proteins |
| 09/21/2004 | US6794359 Vertebrate intestinal protein which absorbs cholesterol, its inhibitors and mehtod of identifying the same |
| 09/21/2004 | US6794145 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 09/16/2004 | WO2004078146A2 Trans-membrane-antibody induced inhibition of apoptosis |
| 09/16/2004 | WO2002050097A3 Anti-allergic complex molecules |
| 09/16/2004 | US20040181041 Fusion protein capable of inducing programmed cell death for use in treatment cell proliferative diseases and infection |
| 09/16/2004 | US20040181039 Canine immunoglobulin variable domains, caninized antibodies, and methods for making and using them |
| 09/16/2004 | US20040181037 Phosphatidyl serine receptors and uses thereof |
| 09/16/2004 | US20040181033 Binding agents which inhibit myostatin |
| 09/16/2004 | US20040180395 Method for detecting calpain3 activity in a biological sample and peptides for implementing said method |
| 09/16/2004 | US20040180386 Using major histocompatibility complex polypeptides as tools in identifying lymphocyte binding sites; immunosuppression and tumor therapeutics |
| 09/16/2004 | US20040180337 Human extracellular signal regulated kinases |
| 09/16/2004 | US20040180052 Bind to AILIM (activation inducible lymphocyte immunomodulatory molecule, also referred to as ICOS (inducible co-stimulator); human monoclonal antibodies which bind to AILIM or a portion thereof; for treating disorders related to the delayed allergy |
| 09/16/2004 | US20040180035 Administering to the mammal (i) an immunoconjugate comprising an antibody binding site capable of binding the preselected cell-type and a cytokine capable of inducing a said immune response against the preselected cell-type, and (ii) an angiogenesis inhibitor to enhance immune response |
| 09/16/2004 | CA2518119A1 Trans-membrane-antibody induced inhibition of apoptosis |
| 09/15/2004 | EP1457500A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalophathies |
| 09/15/2004 | EP1456651A2 Self-assembly molecules |
| 09/15/2004 | EP1456385A2 Growth hormone fusion protein |
| 09/15/2004 | EP1456384A2 Novel alkaline protease from bacillus sp. (dsm 14390) and washing and cleaning products comprising said novel alkaline protease |
| 09/15/2004 | EP1456378A2 Il-17 like molecules and uses thereof |
| 09/15/2004 | EP1456376A2 Novel chimeric rev, tat, and nef antigens |
| 09/15/2004 | EP1456372A2 Emission ratiometric indicators of phosphorylation |
| 09/15/2004 | EP1456368A2 Novel alkaline protease from bacillus sp. (dsm 14392) and washing and cleaning products comprising said novel alkaline protease |
| 09/15/2004 | EP1456367A1 Novel alkaline protease from bacillus gibsonii (dsm 14391) and washing and cleaning agents containing said novel alkaline protease |
| 09/15/2004 | EP1456366A1 Novel alkali protease formed by bacillus gibsonii (dsm 14393) and washing and cleaning agents containing said novel alkali protease |
| 09/15/2004 | EP1456241A2 Mono-and dual anti-cd4-rantes chemokine/cytokine constructs |
| 09/15/2004 | EP1456239A2 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 09/15/2004 | EP1456222A2 Non-human primate fc receptors and methods of use |
| 09/15/2004 | EP1455823A2 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 09/15/2004 | EP1007095B1 CHIMERIC TOXINS COMPRISING GnRH FOR TARGETED THERAPY |
| 09/15/2004 | EP0877760B1 Mhc complexes and uses thereof |
| 09/15/2004 | EP0647275B1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 09/15/2004 | EP0624195B1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 09/15/2004 | CN1529757A Fusion Protein for secretion of protein of interest in supernatant of bacterial culture |
| 09/15/2004 | CN1529713A Compositions and methods for therapy and diagnosis of ovarian cancer |
| 09/15/2004 | CN1529710A Recombinant protective protein from streptococcus pneumoniae |
| 09/15/2004 | CN1529619A Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enbancing agents |
| 09/15/2004 | CN1166772C Process for controlling sialylation of protein produced by mammalian cell culture |